stars 1 stars 2 stars 3

InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. InSyBio has recently expanded its offering including a complete set of services that allows the personalization of nutrition, nutraceutical, vitamin and probiotic products. These services are built around InSyBio Personalization Test which allows predicting outcomes and satisfaction of each customer using specific products before even they purchase them. InSyBio has developed an online suite of software tools – called InSyBio Suite – which assists biology researchers in extracting valuable biological knowledge from experimental data. The 3 and 12-month licenses of the InSyBio Suite as well as free 1-month licenses of our platform are provided. InSyBio Suite consists of tools for providing integrated biological information from various sources, while at the same time it is empowered with robust, user-friendly and installation-free bioinformatics tools based on intelligent algorithms and methods. Some of its methodologies have already been published in international scientific journals and conferences while others are under submission for patent approval by its members. The use of InSyBio Suite for biomedical data analyses, reduces the time and cost requirements by at least 80%, increases predictive accuracy of outcome and diagnostic predictive models by at least 10% and allows biomarker and outcome models discovery in low sample size studies. Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece. For more information about our company contact us at info@insybio.com.

InSyBio Questions

The InSyBio annual revenue was $9 million in 2026.

Labros Digonis is the Co-Founder, CEO of InSyBio.

8 people are employed at InSyBio.

The NAICS codes for InSyBio are [54, 541, 541713, 54171, 5417].

The SIC codes for InSyBio are [87, 873].

Top InSyBio Employees

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users